Literature DB >> 9120332

Vibrio cholerae non-O1 septicaemia in a patient with liver cirrhosis and Billroth-II-gastrectomy.

M Halabi1, M Haditsch, F Renner, G Brinninger, H Mittermayer.   

Abstract

This report deals with the first diagnosed case of Vibrio cholerae non-O1 septicaemia in Austria. After a vacation in Tunisia, a 51-year-old male patient with liver cirrhosis and Billroth-II-gastrectomy was admitted to hospital because of abdominal pain, growing ascites, and jaundice. Four days later, the patient developed a single peak of high fever (39.6 degrees C). A blood culture was drawn and treatment with amoxycillin/clavulanic acid commenced. The blood culture yielded Gram-negative comma-like rods which were identified as V. cholerae non-O1.

Entities:  

Mesh:

Year:  1997        PMID: 9120332     DOI: 10.1016/s0163-4453(97)80016-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Role of toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El tor strains deficient in production of cholera toxin and accessory toxins.

Authors:  G Kenneth Haines; Blayne Amir Sayed; Melissa S Rohrer; Verena Olivier; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Vibrio cholerae non-O1, non-O139 bacteraemia associated with pneumonia, Italy 2016.

Authors:  Serena Marinello; Giulia Marini; Giancarlo Parisi; Lorena Gottardello; Lucia Rossi; Valeria Besutti; Anna Maria Cattelan
Journal:  Infection       Date:  2016-11-11       Impact factor: 3.553

3.  Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient.

Authors:  Tatsuo Inoue; Satoshi Kitai; Sousuke Hayaishi; Masatoshi Kudo
Journal:  Clin J Gastroenterol       Date:  2012-10-29

4.  Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review.

Authors:  S Deshayes; C Daurel; V Cattoir; J-J Parienti; M-L Quilici; A de La Blanchardière
Journal:  Springerplus       Date:  2015-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.